A lecture entitled ‘Testicle tumours’ was held at the Faculty of Medicine of the University of Banja Luka on November 27, 2017.
The lecture was organized by the Students’ Association of the Faculty of Medicine and the International Medical Students Exchange Committee of the Republic of Srpska, with Prof. Radoslav Gajanin, Acting Rector as one of the participants.
As urologist Slobodan Hajder of the University clinical centre of the Republic of Srpska states, ‘a testicle tumour today is curable in almost all of its stages, with the percentage of successful outcomes in the range of 90-95%.’
Furthermore, Mr Hajder said that this type of tumour was not that common in male population (1.5%), being responsible for only 5% of all urogenital tumours in this population.
Also, he said that there was no such thing as prevention in cases like this, but only early diagnosis and risk groups – men aged 20-40, especially those whose testicles had not ‘dropped, or persons exposed to certain toxic influences, such as liquor or lacquer .
A usual procedure is for a patient to make an appointment with his GP, and then is sent to a urologist, who performs an ultrasound treatment, which is deemed as the ‘golden standard’ in the testicle tumour diagnosis. This is followed by staging and, as the disease progresses, the consultation of doctors, with the decision on further treatment being made in a multidisciplinary manner, said oncologist Radmila Raseta.
According to her words, the level of chemotherapy is set upon that decision
‘It is the only tumour where the metastasis stage is curable in more than 80%’, pointed out Ms Raseta.
As for the Republic of Srpska, there are around 50 cases of testicle tumour over a year.